⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11991285 | 0.77 | GRIN2D (0.42) | — | |
| SCHEMBL28305910 | 0.76 | GRIN2D (0.41) | — | |
| SCHEMBL19035375 | 0.75 | CYP1A2 (0.30) | — | |
| SCHEMBL23226021 | 0.72 | ALDH1A1 (0.34) | — | |
| SCHEMBL15293054 | 0.70 | CYP1A2 (0.32) | — | |
| SCHEMBL226326 | 0.69 | — | — | |
| SCHEMBL3612425 | 0.68 | GRIN2D (0.36) | — | |
| SCHEMBL20857957 | 0.67 | — | — | |
| SCHEMBL189533 | 0.67 | POLB (0.48) | — | |
| SCHEMBL18306964 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025133665-A1 | OIL-IN-WATER EMULSION | L V M H RECHERCHE (FR) | 2025-06-26 | — | — | WO | disclosed |
| EP-4452208-A1 | AQUEOUS EMULSION | L V M H RECHERCHE (FR) | 2024-10-30 | — | — | EP | disclosed |
| CN-118510486-A | Aqueous emulsion | LVMH研究公司 | 2024-08-16 | — | — | CN | disclosed |
| US-11793742-B2 | Mixtures of cosmetic UV absorbers | BASF SE (DE) | 2023-10-24 | — | — | US | disclosed |
| WO-2023118912-A1 | AQUEOUS EMULSION | L V M H RECHERCHE (FR) | 2023-06-29 | — | — | WO | disclosed |
| CN-115746946-A | Preparation method of cracked transformer reclaimed oil based on graphene column chromatography | 国网浙江省电力有限公司绍兴供电公司 | 2023-03-07 | — | — | CN | disclosed |
| US-11458083-B2 | Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities | L'OREAL (FR) | 2022-10-04 | — | — | US | disclosed |
| EP-3923989-A1 | MULTIVALENT LIGAND CLUSTERS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | Mitotherapeutix LLC (US) | 2021-12-22 | — | — | EP | disclosed |
| US-11044931-B2 | Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof | BASF SE (DE) | 2021-06-29 | — | — | US | disclosed |
| US-11046814-B2 | Ultraviolet radiation absorbing polymer composition | BASF SE (DE) | 2021-06-29 | — | — | US | disclosed |
| US-20060165620-A1 | Coloured gloss pigments having at least one coating of siox, with x=0.03 to 0.95 for use in cosmetic and personal care formulations | CIBA SPECIALTY CHEMICALS CORP. | 2006-07-27 | — | — | US | disclosed |
| US-20060153783-A1 | Triazine derivatives as uv absorbers | BASF SE (DE) | 2006-07-13 | — | — | US | disclosed |
| US-20050255055-A1 | Merocyanine derivatives for cosmetic use | CIBA SPECIALTY CHEMICALS CORP. | 2005-11-17 | — | — | US | disclosed |
| US-20050175554-A1 | Aminophenylbenzothiazole compounds | CIBA SPECIALTY CHEMICALS CORP. | 2005-08-11 | — | — | US | disclosed |
| US-20050129632-A1 | Uv absorber compositions comprising a hydroxyphenyltriazine compound | CIBA SPECIALTY CHEMICALS CORP. | 2005-06-16 | — | — | US | disclosed |
| EP-1119568-B1 | 4,5-DIHYDRO-ISOXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | JANSSEN PHARMACEUTICA NV (BE) | 2004-02-18 | — | — | EP | disclosed |
| US-20040019059-A1 | 4,5-Dihydro-isoxazole derivatives and their pharmaceutical use | FREYNE EDDY JEAN EDGARD (BE) | 2004-01-29 | — | — | US | disclosed |
| US-6583141-B1 | T cell mediated rheumatic diseases | JANSSEN PHARMACEUTICA, N.V. (BE) | 2003-06-24 | — | — | US | disclosed |
| EP-1119568-A1 | 4,5-DIHYDRO-ISOXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-08-01 | — | — | EP | disclosed |
| WO-2000021959-A1 | 4,5-DIHYDRO-ISOXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-04-20 | — | — | WO | disclosed |